Sunshine Biopharma (SBFM) Retained Earnings (2010 - 2026)
Sunshine Biopharma (SBFM) posted Retained Earnings of $98.1 million for Q1 2026, up 150310.52% on a QoQ basis from -$65309.0 in Q4 2025, and up 12305.11% year-over-year from N/an in Q1 2025.
Sunshine Biopharma (SBFM) Retained Earnings (2010 - 2026) Analysis & Trends
Sunshine Biopharma's Retained Earnings history runs 16 years deep, the most recent figure standing at $98.1 million for Q1 2026.
- Quarterly Retained Earnings rose 12305.11% year-over-year to $98.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $98.1 million (up 12305.11% YoY) and the FY2025 annual result came in at -$65309.0, up 99.91% from the prior year.
- Retained Earnings was $98.1 million for Q1 2026 at Sunshine Biopharma, up from -$65309.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $98.1 million in Q1 2026 and bottomed at -$72.0 million in Q2 2025.
- A 5-year average of $15.1 million and a median of $152400.0 in 2024 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings slumped 295794.47% — and 2024, when it soared 44748.56%.
- Sunshine Biopharma's Retained Earnings stood at -$59.4 million in 2022, then jumped by 101.17% to $696105.0 in 2023, then slumped by 10018.01% to -$69.0 million in 2024, then soared by 99.91% to -$65309.0 in 2025, then soared by 150310.52% to $98.1 million in 2026.
- Business Quant data shows SBFM's Retained Earnings at $98.1 million in Q1 2026, -$65309.0 in Q4 2025, and -$320841.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 8.83 Bn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | -413.76 Mn |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn | 98.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.10 Mn |
| Dec 31, 2025 | -65,309.00 |
| Sep 30, 2025 | -320,841.00 |
| Jun 30, 2025 | -71.99 Mn |
| Mar 31, 2025 | -803,770.00 |
| Dec 31, 2024 | -69.04 Mn |
| Sep 30, 2024 | 91.74 Mn |
| Jun 30, 2024 | 89.84 Mn |
| Mar 31, 2024 | 152,400.00 |
| Dec 31, 2023 | 696,105.00 |
| Sep 30, 2023 | 204,549.00 |
| Jun 30, 2023 | 84.42 Mn |
| Mar 31, 2023 | 80.34 Mn |
| Dec 31, 2022 | -59.40 Mn |
| Sep 30, 2022 | -79,903.00 |
| Jun 30, 2022 | -34.43 Mn |
| Mar 31, 2022 | 47.22 Mn |
| Dec 31, 2021 | -32.66 Mn |
| Sep 30, 2021 | 31.56 Mn |
| Jun 30, 2021 | -11,636.00 |